
A recent study sheds light on the dynamics of synaptic loss in Alzheimer's disease (AD) and its relationship with tau pathology. In patients with amnestic mild cognitive impairment (aMCI), tau levels increased over two years in Braak regions III–VI but plateaued in early Braak regions (I–II). Synaptic vesicle protein 2A (SV2A), a marker of synaptic density, declined across all Braak regions in aMCI. Notably, baseline tau levels were negatively correlated with longitudinal SV2A loss in early Braak regions and cognitive decline over time.
Like
Save
Share